Recruiting Multiple Myeloma Studies in Fairbanks
About Multiple Myeloma Clinical Trials in Fairbanks
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 1 multiple myeloma clinical trials recruiting participants in Fairbanks, ALASKA. These studies are seeking a combined 288 participants. Research is being sponsored by ECOG-ACRIN Cancer Research Group. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Fairbanks — FAQ
Are there multiple myeloma clinical trials in Fairbanks?
Yes, there are 1 multiple myeloma clinical trials currently recruiting in Fairbanks, ALASKA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fairbanks?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairbanks research site will contact you about next steps.
Are clinical trials in Fairbanks free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairbanks studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 1 active trials in Fairbanks are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated March 2, 2026 from ClinicalTrials.gov